AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sigvio M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alvio Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sigvio M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflex DM 50mg/500mg may be used alone or with other diabetes treatments, and is most effective when coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood glucose levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't suitable for everyone. Prior to use, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals must consult their doctor. Interactions with other medications are possible; complete medication disclosure is necessary for safe use. Alcohol consumption should be minimized due to its potential to lower blood glucose. Kidney function and blood sugar will be monitored by your doctor throughout treatment.

Primary Ingredients of Sigvio M 50mg/500mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Sigvio M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sigvio M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or breaking it. The Sigvio M 50mg/500mg tablet should be taken with a meal.

Common Side effects of Sigvio M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sigvio M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sigvio M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with meals.

How Sigvio M 50mg/500mg Tablet works:

Each Sigvio M 50mg/500mg tablet unites sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sigvio M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sigvio M 50mg/500mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sigvio M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sigvio M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Sigvio M 50mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Sigvio M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sigvio M 50mg/500mg Tablet :

Should you forget to take a Sigvio M 50mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sigvio M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sigvio M 50mg/500mg Tablet

Sigvio M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sigvio M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sigvio M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sigvio M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sigvio M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Yes, Sigvio M 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sigvio M and seek immediate medical attention.
Sigvio M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sigvio M 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sigvio M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sigvio M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, Sigvio M 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sigvio M and seek immediate medical attention.
Prolonged use of Sigvio M 50mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Sigvio M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sigvio M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with allergies to Sigvio M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sigvio M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, Sigvio M 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these symptoms, discontinue Sigvio M and seek immediate medical attention.
Prolonged use of Sigvio M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sigvio M 50mg/500mg Table...
194